| Trial With Eribulin or Eribulin+ Endocrine Therapy in Locally-recurrent or Metastatic Breast Cancer Patients (NCT03795012) | MedSIR | 2019-04-30 |
| Melatonin Cream Against Acute Radiation Dermatitis in Patients With Early Breast Cancer (NCT03716583) | Dennis Bregner Zetner | 2019-04-30 |
| Pre Pectoral Implant for Immediate Breast Reconstruction Using Single Port Endoscopy in Prophylactic Indication (NCT03838549) | University Hospital, Montpellier | 2019-04-26 |
| Aromatase Inhibitor and Durvalumab in Postmenopausal Breast Cancer (NCT03874325) | H. Lee Moffitt Cancer Center and Research Institute | 2019-04-26 |
| The Psychology of Chinese Breast Cancer Patients (NCT05055375) | Ma Fei，MD | 2019-04-25 |
| Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Breast Cancer (NCT04145960) | Peking Union Medical College Hospital | 2019-04-25 |
| HeartPhone Cancer Survivors Trial 2019 (NCT03953326) | Penn State University | 2019-04-23 |
| Diet Restriction and Exercise-induced Adaptations in Metastatic Breast Cancer (NCT03795493) | University of Alberta | 2019-04-23 |
| Feasibility of a Modular mHealth for Tailored Rehabilitation of Breast Cancer (NCT04781712) | Samsung Medical Center | 2019-04-22 |
| Phase II Multi-center Trial Evaluating 5 Fraction Stereotactic Partial Breast Irradiation Using Gammapod (NCT03581136) | University of Texas Southwestern Medical Center | 2019-04-22 |
| Phase II Clinical Study of Pyrotinib Combined With Etoposide to Treat HER2-positive Advanced Breast Cancer (NCT03923179) | Chinese Academy of Medical Sciences | 2019-04-19 |
| Window of Opportunity Trial, PARP Inhibitor Rucaparib Affect on PD-L1 Expression in Triple Negative Breast Tumors (NCT03911453) | University of Arizona | 2019-04-19 |
| Pyrotinib Combined With Capecitabine Metronomic Therapy in HER2-postitive Advanced Breast Cancer (NCT03923166) | Chinese Academy of Medical Sciences | 2019-04-19 |
| Lymphedema Evaluation After Adjuvant Hypofractionated Radiotherapy for 1-2 Macrometastatic Sentinel Lymph Nodes (NCT06321653) | European Institute of Oncology | 2019-04-18 |
| TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer (NCT03964532) | Georgetown University | 2019-04-17 |
| To Reduce the Use of Chemotherapy in Postmenopausal Patients With ER-positive and HER2-positive Breast Cancer (TOUCH) (NCT03644186) | ETOP IBCSG Partners Foundation | 2019-04-16 |
| MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour (NCT03934827) | Imperial College London | 2019-04-10 |
| PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA) (NCT03809988) | MedSIR | 2019-04-05 |
| [18F] F-GLN by PET/CT in Breast Cancer (NCT03863457) | Abramson Cancer Center at Penn Medicine | 2019-04-05 |
| Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients (NCT03650894) | Providence Health & Services | 2019-04-03 |
| Inertial Rehabilitation in Women After Mastectomy (NCT04621942) | University in Zielona Góra | 2019-04-02 |
| Intravenous Chemotherapy and Plant-based Dietary Supplements (NCT03959618) | Institut Cancerologie de l'Ouest | 2019-04-02 |
| The Immersive Experience of Virtual Reality During Chemotherapy in Patients With Early Breast and Gynecological Cancers: the Patient's Dream Study (NCT05234996) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2019-04-01 |
| Neoadjuvant Nab-paclitaxel in Triple-negative or HER2-positive Breast Cancer (NCT03907800) | Ruijin Hospital | 2019-04-01 |
| An Enhanced Artificial Intelligence Breast MRI Interpretation System (NCT03829423) | Jamil Kanfoud | 2019-04-01 |
| Study Comparing 4 Cycles With 6 Cycles of TC (Docetaxel+Cyclophosphamide) Adjuvant Chemotherapy for 1-3 Lymph Node Positive ER+/HER2- Early Breast Cancer (NCT03926091) | Fudan University | 2019-04-01 |
| Evaluation of Prognostic Monitoring for Breast Cancer Patients With Recurrence and Metastasis After Surgery (NCT04145973) | Peking Union Medical College Hospital | 2019-04-01 |
| Chronic Pain and Minor Breast Cancer Surgery (NCT03912948) | Institut Claudius Regaud | 2019-04-01 |
| The REACH Study: A Novel Values-Based Intervention to Increase Endocrine Therapy Adherence Among Breast Cancer Survivors (NCT03980093) | University of Colorado, Boulder | 2019-04-01 |
| Evaluation of Individual Sensitivity to the Gonadotoxicity of Chemotherapy in Young Patients With Breast Cancer (NCT03731845) | Assistance Publique - Hôpitaux de Paris | 2019-04-01 |
| PCR Based CEUS in BI RADS 4A Nodules (NCT04929054) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2019-04-01 |
| A Window-of-opportunity Study of Pelareorep in Early Breast Cancer (NCT04102618) | Oncolytics Biotech | 2019-03-29 |
| Evaluation of Orally Administered Amcenestrant (SAR439859) in Japanese Postmenopausal Patients With Advanced Breast Cancer (AMEERA-2) (NCT03816839) | Sanofi | 2019-03-25 |
| A Study of Limited Heart Monitoring During Non-anthracycline Trastuzumab-based Therapy in Breast Cancer Patients (NCT03983382) | Memorial Sloan Kettering Cancer Center | 2019-03-22 |
| 'ADVANCE' (A Pilot Trial) (NCT03858322) | Dana-Farber Cancer Institute | 2019-03-21 |
| The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology) (NCT03896958) | SpeciCare | 2019-03-21 |
| Prospective Study of the Prosigna Assay on Neoadjuvant Clinical Decision-making in Women With HR+/Her2- Breast Cancer (NCT03749421) | Dana-Farber Cancer Institute | 2019-03-21 |
| Hyperventilation and Oxygenation to Prolong Breath Hold in Breast Cancer Irradiation Treatment (NCT04091542) | University Hospital, Ghent | 2019-03-15 |
| Evaluation of the Effects of the Couple-based Family Nursing for Women With Breast Cancer (NCT05100914) | National Defense Medical Center, Taiwan | 2019-03-14 |
| In Vivo Smart Biopsy Device Protocol In Radiology (NCT03914911) | Dune Medical Devices | 2019-03-14 |
| Efficacy Study of Mepitel Film the Prophylaxis of Radiation-Induced Skin Reactions in Breast Cancer Patients (NCT03910595) | Sunnybrook Health Sciences Centre | 2019-03-14 |
| PROactive Evaluation of Function to Avoid CardioToxicity (NCT03862131) | Washington University School of Medicine | 2019-03-13 |
| EHR-embedded OCDT in Breast or GI Cancer (NCT03858712) | Dana-Farber Cancer Institute | 2019-03-13 |
| Comparison of Pre-op and Post-op Pectoralis Nerve Block (NCT03653988) | Melinda Seering | 2019-03-12 |
| DWIBS-MRI: An Adjunct to the Traditional Diagnostic Breast Imaging Evaluation (NCT04491864) | Baylor Research Institute | 2019-03-11 |
| Vacuum Assisted Biopsy and Surgery Correlation in HER2 and TN Breast Cancer Subtypes MRI Responders After Neoadjuvant Therapy: BISUCO TRIAL (NCT06371989) | Hospital Universitario 12 de Octubre | 2019-03-11 |
| Yoga for Aromatase Inhibitor-related Knee Pain Relief in Breast Cancer Patients (NCT03956875) | China Medical University Hospital | 2019-03-10 |
| NIMBUS: Nivolumab Plus Ipilimumab in Metastatic Hypermutated HER2-negative Breast Cancer (NCT03789110) | Dana-Farber Cancer Institute | 2019-03-08 |
| HERPET- A Novel PET Imaging Study of HER2 in Breast Cancer (NCT03827317) | Imperial College London | 2019-03-08 |
| A Mind-Body Intervention for Hot Flash Management (NCT03572153) | Baylor University | 2019-03-04 |
| MRI-guided Single Dose Preoperative Radiotherapy in Low-risk Breast Cancer (NCT03863301) | UMC Utrecht | 2019-03-04 |
| Curcumin in Reducing Joint Pain in Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint Disease (NCT03865992) | City of Hope Medical Center | 2019-03-04 |
| Study Evaluating GZ17-6.02 in Patients With Advanced Solid Tumors or in Combination With Capecitabine in Metastatic Hormone Receptor Positive Breast Cancer (NCT03775525) | Genzada Pharmaceuticals USA, Inc. | 2019-03-01 |
| Alpha-Lipoic Acid in Breast Cancer Patients (NCT03908528) | Damanhour University | 2019-03-01 |
| A Study to Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast Cancer (NCT03632941) | Herbert Lyerly | 2019-03-01 |
| A Community Dance Intervention Engaging Breast Cancer Survivors in a Middle-income Country (NCT05252780) | Olga Lucia Sarmiento | 2019-03-01 |
| BrUOG 351: PRE-OPERATIVE APBI USING NIBB (NCT03437915) | Jaroslaw Hepel | 2019-03-01 |
| Tomosynthesis as Primary Test for Breast Cancer Screening (NCT04461808) | Azienda USL Reggio Emilia - IRCCS | 2019-03-01 |
| Image-guided De-escalation of Neo-adjuvant Chemotherapy in HER2-positive Breast Cancer: the TRAIN-3 Study (NCT03820063) | Borstkanker Onderzoek Groep | 2019-02-27 |
| Gedatolisib, Hydroxychloroquine or the Combination for Prevention of Recurrent Breast Cancer ("GLACIER") (NCT03400254) | Abramson Cancer Center at Penn Medicine | 2019-02-26 |
| Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer (NCT03839823) | Novartis Pharmaceuticals | 2019-02-25 |
| Tissue Expansion in Breast Reconstruction Without Drains (NCT03784859) | Cedars-Sinai Medical Center | 2019-02-25 |
| GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases (NCT03765983) | Dana-Farber Cancer Institute | 2019-02-25 |
| Automated Low Dose Risk Assessment Mammography (ALDRAM) (NCT05796219) | Manchester University NHS Foundation Trust | 2019-02-22 |
| Nab-paclitaxel Dose Schedual for HER-2 Negative Advanced Breast Cancer (NCT04192331) | Peking University Cancer Hospital & Institute | 2019-02-21 |
| Hypofractionated Irradiation At Regional Nodal Area for Breast Cancer Vs Existed Standard Treatment (NCT03829553) | Ruijin Hospital | 2019-02-21 |
| Fish Oil and EPO in Breast Cancer (NCT03516253) | University of Belgrade | 2019-02-20 |
| The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer (NCT04129216) | Johns Hopkins University | 2019-02-20 |
| Elevate! : An Elderly Breast Cancer Cohort Study (NCT03818087) | Dana-Farber Cancer Institute | 2019-02-19 |
| Screening CEDM in Intermediate and High-Risk Patient Populations (NCT03859492) | Mayo Clinic | 2019-02-15 |
| 18F-FES PET/CT's Additional Clinical Value in ER+ BC (NCT04006626) | Fudan University | 2019-02-15 |
| CFI-400945 in Patients With Advanced/Metastatic Breast Cancer (NCT03624543) | Canadian Cancer Trials Group | 2019-02-14 |
| Evaluation of NeoNavia® Biopsy System in Axillary Lymph Nodes (NCT03975855) | NeoDynamics AB | 2019-02-14 |
| Imaging of Primary or Recurrent Breast Cancer With 18F-FluorThanatrace PET/CT (NCT03846167) | University of Pennsylvania | 2019-02-11 |
| Assessing the Utility of Tissue Dielectric Constant (TDC) Measurements to Differentiate Breast Cancer From Healthy Breasts (NCT04561297) | Nova Southeastern University | 2019-02-08 |
| Involvement of SK3 Calcium Channel in Taxane Neuropathy (NCT03816904) | University Hospital, Tours | 2019-02-06 |
| Tesetaxel Plus Reduced Dose of Capecitabine in Patients With HER2 Negative, HR Positive, LA/MBC (NCT03858972) | Odonate Therapeutics, Inc. | 2019-02-05 |
| CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer (NCT03568422) | Canadian Cancer Trials Group | 2019-02-05 |
| Opioid Free Anaesthesia in Oncologic Gynaecological Surgery: Is There Any Benefit? (NCT05448586) | Instituto de Investigación Hospital Universitario La Paz | 2019-02-02 |
| Immunonutrition and Carbohydrate Loading Strategies in Breast Reconstruction (NCT03764943) | University of Wisconsin, Madison | 2019-02-01 |
| CO2 Laser Therapy for the Treatment of GSM in Patients With Breast Cancer (NCT04517370) | Hadassah Medical Organization | 2019-02-01 |
| The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study (NCT04075305) | UMC Utrecht | 2019-02-01 |
| Exploring Cancer-Associated Thromboembolism Prognosis Biomarkers and Polymorphisms (NCT06065592) | Lebanese University | 2019-02-01 |
| A Pilot Study of Tomographic Optical Breast Imaging (DBT-TOBI) to Monitor Response to Neoadjuvant Therapy (NCT03822312) | Massachusetts General Hospital | 2019-02-01 |
| Capecitabine in the Treatment of Breast Cancer With Low-hormone Receptor Expression After Neoadjuvant Chemotherapy (NCT03821454) | Zhejiang Cancer Hospital | 2019-02-01 |
| Exploring the Efficacy and Feasibility of the LymphaTech Scanner for Breast Cancer-Related Lymphedema Screening (NCT03861975) | Massachusetts General Hospital | 2019-01-30 |
| Light Emitting Diode for theTreatment of Genitourinary Syndrome of Menopause Associated With Breast Cancer Treatment (NCT03833726) | Centro de Atenção ao Assoalho Pélvico | 2019-01-30 |
| Assessment of Feasibility and Acceptability of Personalized Breast Cancer Screening (NCT03791008) | Institut de Recerca Biomèdica de Lleida | 2019-01-30 |
| A Pilot Study of the Combination of Entinostat With Capecitabine in High Risk Breast Cancer After Neo-adjuvant Therapy (NCT03473639) | University of Virginia | 2019-01-29 |
| Neoadjuvant Her2-targeted Therapy and Immunotherapy With Pembrolizumab [IIT2018-04-MCARTHUR-NEOHP] (NCT03747120) | University of Texas Southwestern Medical Center | 2019-01-25 |
| Awareness About Breast Cancer Screening (NCT03777397) | Hospices Civils de Lyon | 2019-01-24 |
| Physical Activity Platform to Improve Bone Health in Cancer Survivors (NCT03651037) | Thrivors Inc | 2019-01-21 |
| Role of Sorcin and Annexin A3 in Breast Cancer Patients (NCT03598660) | Assiut University | 2019-01-20 |
| Tumor-Infiltrating Lymphocytes and Programmed Cell Death - Ligand 1 in Breast Cancer (NCT05250336) | Sanjay Gandhi Postgraduate Institute of Medical Sciences | 2019-01-19 |
| Decisions of Young Women With Breast Cancer Regarding Fertility Preservation Before Cancer Treatment and Family Building After Treatment (NCT03817814) | Memorial Sloan Kettering Cancer Center | 2019-01-18 |
| Application of Ultrasound Artificial Intelligence and Elastography in Differential Diagnosis of Breast Nodules (NCT03887598) | Xin-Wu Cui | 2019-01-18 |
| A Phase 1 Study of [225Ac]-FPI-1434 Injection (NCT03746431) | Fusion Pharmaceuticals Inc. | 2019-01-17 |
| Demonstration of a Novel Approach Using Surface-Image Guidance to Improve Delivery of Breast Radiotherapy (NCT03799523) | The University of Texas Health Science Center at San Antonio | 2019-01-16 |
| Emotion Regulation and Cancer Caregiving (NCT06123416) | Stanford University | 2019-01-16 |
| Role of Magnetic Resonance Fingerprinting and Quantitative MR Imaging in Breast Cancer (NCT03650803) | Case Comprehensive Cancer Center | 2019-01-14 |